SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma

New England Journal of Medicine

Volumn 338, Issue 3, 1998, Pages 153-160

  Kawai, Akira ^a   Woodruff, James ^a   Healey, John H ^a   Brennan, Murray F ^a   Antonescu, Cristina R ^a   Ladanyi, Marc ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 18; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FUSION; HISTOLOGY; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROGNOSIS; PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SARCOMA, SYNOVIAL; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; X CHROMOSOME;

EID: 0032518634     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199801153380303     Document Type: Article

References (35)

1. Enzinger PM, Weiss SW. Synovial sarcoma. In: Enzinger FM, Weiss SW, eds. Soft tissue tumors. 3rd ed. St. Louis: Mosby, 1995:757-86.
2. Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RSK. Chromosomal aberrations in soft tissue tumors: relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 1994;144:1121-34.
3. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994;7:502-8.
4. de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas. Hum Mol Genet 1995;4: 1097-9.
5. Crew AJ, Clark J, Fisher C, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995;14:2333-40.
6. de Leeuw B, Balemans M, Geurts van Kessel A. A novel Kruppel-associated box containing the SSX gene (SSX3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas. Cytogenet Cell Genet 1996;73:179-83.
7. Chand A, Clark J, Cooper CS, Craig IW. Long-range organization of reiterated sequences, including the SSX1 cDNA at the OATL1 cluster in Xp11.23. Genomics 1995;30:545-52.
8. Ladanyi M. The emerging molecular genetics of sarcoma translocations Diagn Mol Pathol 1995;4:162-73.
9. Sorensen PH, Triche TJ. Gene fusions encoding chimaeric transcription factors in solid rumours. Semin Cancer Biol 1996;7:3-14.
10. Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 1997;6:1559-64.
11. dos Santos NR, de Bruijn DRH, Balemans M, et al. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. Hum Mol Genet 1997;6:1549-58.
12. de Leeuw B, Suijkerbuijk RF, Olde Weghuis D, et al. Distinct Xp11.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: relationship to histologic subtypes. Cancer Genet Cytogenet 1994;73:89-94.
13. Janz M, De Leeuw B, Weghuis DO, et al. Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma. J Pathol 1995;175:391-6.
14. Renwick PJ, Reeves BR, Dal Cin P, et al. Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma. Cytogenet Cell Genet 1995;70:58-63.
15. Shipley JM, Clark J, Crew AJ, et al. The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene 1994;9:1447-53.
16. Shipley J, Crew J, Birdsall S, et al. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol 1996;148:559-67.
17. Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol 1995;147:1592-9.
18. Kampe CE, Rosen G, Eilber F, et al. Synovial sarcoma: a study of intensive chemotherapy in 14 patients with localized disease. Cancer 1993;72:2161-9.
19. Kaplan EL, Meier P. Nonparamctric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
20. Rosen G, Forscher C, Lowenbraun S, et al. Synovial sarcoma: uniform response of metastases to high dose ifosfamide. Cancer 1994;73:2506-11.
21. Connelly EF, Budd GT. Ifosfamide in the treatment of soft tissue sarcomas. Semin Oncol 1996;23:Suppl 6:16-21.
22. Limon J, Mrozek K, Mandahl N, et al. Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer 1991;3:338-45.
23. Cagle LA, Mirra JM, Storm FK, Roc DJ, Eilber FR. Histologic features relating to prognosis in synovial sarcoma. Cancer 1987;59:1810-4.
24. Rooser B, Willen H, Hugoson A, Rydholm A. Prognostic factors in synovial sarcoma. Cancer 1989;63:2182-5.
25. Brodsky JT, Burt ME, Hajdu SI, Casper ES, Brennan MF. Tendosynovial sarcoma: clinicopathologic features, treatment, and prognosis. Cancer 1992;70:484-9.
26. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. Survival in synovial sarcoma: a multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol 1993;17:35-44.
27. Pappo AS, Fontanesi J, Luo X, et al. Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience. J Clin Oncol 1994;12:2360-6.
28. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol 1996;14:1201-8.
29. Krall RA, Kostianovsky M, Patchefsky AS. Synovial sarcoma: a clinical, pathological, and ultrastructural study of 26 cases supporting the recognition of a monophasic variant. Am J Surg Pathol 1981;5:137-51.
30. Pisters PW, Leung DH, Woodruff I, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-89.
31. Argani P, Zakowski MF, Klimstra DS, Rosai J, Ladanyi M. Detection of the SΥT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol (in press).
32. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996;88:2375-84.
33. Kelly KM, Womer RB, Sorensen PHB, Xiong QB, Barr FG. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997;15:1831-6.
34. Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996;14:1245-51.
35. de Alava E, Kawai A, Healey JH, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol (in press).